The synergy of Vitamin C with decitabine activates TET2 in leukemic cells and significantly improves overall survival in elderly patients with acute myeloid leukemia
H Zhao, H Zhu, J Huang, Y Zhu, M Hong, H Zhu… - Leukemia research, 2018 - Elsevier
Background Decitabine is widely used in the treatment of acute myeloid leukemia (AML) in
elderly patients. Low-dose Vitamin C has also been indicated to induce DNA demethylation …
elderly patients. Low-dose Vitamin C has also been indicated to induce DNA demethylation …
[PDF][PDF] The synergy of Vitamin C with decitabine activates TET2 in leukemic cells and significantly improves overall survival in elderly patients with acute myeloid …
H Zhao, H Zhu, J Huang, Y Zhu… - Leukemia …, 2018 - portmoodyintegratedhealth.ca
Background: Decitabine is widely used in the treatment of acute myeloid leukemia (AML) in
elderly patients. Low-dose Vitamin C has also been indicated to induce DNA demethylation …
elderly patients. Low-dose Vitamin C has also been indicated to induce DNA demethylation …
The synergy of Vitamin C with decitabine activates TET2 in leukemic cells and significantly improves overall survival in elderly patients with acute myeloid leukemia.
H Zhao, H Zhu, J Huang, Y Zhu, M Hong… - Leukemia …, 2018 - europepmc.org
Background Decitabine is widely used in the treatment of acute myeloid leukemia (AML) in
elderly patients. Low-dose Vitamin C has also been indicated to induce DNA demethylation …
elderly patients. Low-dose Vitamin C has also been indicated to induce DNA demethylation …
[PDF][PDF] The synergy of Vitamin C with decitabine activates TET2 in leukemic cells and significantly improves overall survival in elderly patients with acute myeloid …
H Zhao, H Zhu, J Huang, Y Zhu, M Hong… - Leukemia …, 2018 - portmoodyhealth.com
Background: Decitabine is widely used in the treatment of acute myeloid leukemia (AML) in
elderly patients. Low-dose Vitamin C has also been indicated to induce DNA demethylation …
elderly patients. Low-dose Vitamin C has also been indicated to induce DNA demethylation …
[引用][C] The synergy of Vitamin C with decitabine activates TET2 in leukemic cells and significantly improves overall survival in elderly patients with acute myeloid …
H Zhao, H Zhu, J Huang, Y Zhu, M Hong, H Zhu… - Leukemia …, 2018 - cir.nii.ac.jp
The synergy of Vitamin C with decitabine activates TET2 in leukemic cells and significantly
improves overall survival in elderly patients with acute myeloid leukemia | CiNii Research CiNii …
improves overall survival in elderly patients with acute myeloid leukemia | CiNii Research CiNii …
The synergy of Vitamin C with decitabine activates TET2 in leukemic cells and significantly improves overall survival in elderly patients with acute myeloid leukemia
H Zhao, H Zhu, J Huang, Y Zhu, M Hong… - Leukemia …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Decitabine is widely used in the treatment of acute myeloid leukemia (AML) in
elderly patients. Low-dose Vitamin C has also been indicated to induce DNA demethylation …
elderly patients. Low-dose Vitamin C has also been indicated to induce DNA demethylation …